These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Stimulation by gastrin-releasing peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro. Kabayama Y; Kato Y; Shimatsu A; Yanaihara N; Imura H Brain Res; 1986 May; 372(2):394-9. PubMed ID: 3085873 [TBL] [Abstract][Full Text] [Related]
68. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors. Millan MJ; Bervoets K; Mavridis M Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876 [TBL] [Abstract][Full Text] [Related]
69. Dopaminergic receptors in bovine retina and their interaction with thyrotropin-releasing hormone. Reading HW J Neurochem; 1983 Dec; 41(6):1587-95. PubMed ID: 6417273 [TBL] [Abstract][Full Text] [Related]
70. Brain thyrotropin-releasing hormone matures independently of the hypothalamus in the rat. Mori M; Kobayashi I; Wilber JF Horm Metab Res; 1985 Apr; 17(4):181-3. PubMed ID: 3924809 [TBL] [Abstract][Full Text] [Related]
71. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061 [TBL] [Abstract][Full Text] [Related]
72. Glucocorticoids inhibit D1B, but not D2, receptor-mediated effects on hypothalamic atrial natriuretic factor neurons. Lee D; Huang W; Copolov DL; Lim AT Endocrinology; 1995 Dec; 136(12):5570-6. PubMed ID: 7588310 [TBL] [Abstract][Full Text] [Related]
73. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763 [TBL] [Abstract][Full Text] [Related]
74. Alterations in levels of thyrotrophin releasing hormone and rates of hormone degradation in hypothalamic tissue of the developing rat. Pease K; Shen H; Acres GS; Rupnow JH; Dixon JE J Endocrinol; 1980 Apr; 85(1):55-61. PubMed ID: 6771355 [TBL] [Abstract][Full Text] [Related]
75. Interaction between thyrotrophin-releasing hormone and the muscarinic cholinergic system in rat brain. Garcia SI; Dabsys SM; Santajuliana D; Delorenzi A; Finkielman S; Nahmod VE; Pirola CJ J Endocrinol; 1992 Aug; 134(2):215-9. PubMed ID: 1402531 [TBL] [Abstract][Full Text] [Related]
76. Studies on the nature of mammalian hypothalamic thyrotrophin releasing hormone using immunochemical, chromatographic and enzymic techniques. Jeffcoate SL; White N J Endocrinol; 1975 Apr; 65(1):83-90. PubMed ID: 806647 [TBL] [Abstract][Full Text] [Related]
77. Human fetal hypothalamic GnRH neurosecretion: dopaminergic regulation in vitro. Rasmussen DD; Liu JH; Swartz WH; Tueros VS; Yen SS Clin Endocrinol (Oxf); 1986 Aug; 25(2):127-32. PubMed ID: 3539416 [TBL] [Abstract][Full Text] [Related]
78. Neurotensin perfusion of rat hypothalamus: dissociation of dopamine release from body temperature change. Myers RD; Lee TF Neuroscience; 1984 May; 12(1):241-53. PubMed ID: 6462447 [TBL] [Abstract][Full Text] [Related]
79. [The effect of the dopamine D2 receptor agonist cabergoline on the content of catecholamines and expression of BDNF mRNA in the rat midbrain and hypothalamus]. Anokhin PK; Veretinskaya AG; Pavshintsev VV; Shamakina IY Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):54-59. PubMed ID: 31851173 [TBL] [Abstract][Full Text] [Related]
80. D-1 and D-2 dopaminergic receptors regulate protein phosphorylation in the rat neurohypophysis. Treiman M; Greengard P Neuroscience; 1985 Jul; 15(3):713-22. PubMed ID: 2415870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]